We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EMA Approve Novel Hep C Drugs Offering Alternative Treatment Approach
FDA, EMA Approve Novel Hep C Drugs Offering Alternative Treatment Approach
Regulators in the U.S. and EU have paved the way for a new treatment approach to treat chronic hepatitis C, clearing highly anticipated new drugs from Gilead Sciences and Janssen/Medivir.